Showing posts with label Fertility Testing Market. Show all posts
Showing posts with label Fertility Testing Market. Show all posts

Thursday, February 16, 2023

Fertility Testing – Role of Leading Companies in Global Industry Growth

 Major Growth Influencing Factors:

 

1. Increasing Prevalence of Infertility: The prevalence of infertility has been increasing significantly in recent years, due to factors such as environmental factors, unhealthy lifestyle, delayed marriages, and increasing stress levels. This has led to an increased demand for fertility testing services.

 

2. Rising Awareness: Growing awareness among people about the availability of fertility tests and their effectiveness has also been a major factor driving the industry.

 

3. Technological Advancements: Technological advancements in fertility testing technologies have made the tests more accurate and cost-effective, thereby driving the industry.

 

4. Increase in Government Initiatives: Governments across the world have been taking several initiatives to promote fertility testing and other treatments. This has also been driving the industry.

 

5. Rise in Single Parenthood: The rise in single-parent households and couples opting for fertility treatments has also been an important factor driving the industry.

 

Importance of Advanced Technologies for Fertility Testing:

 

Advanced technology plays an important role in fertility testing. It helps to detect underlying problems and make more accurate diagnoses. With advanced technology, healthcare providers can accurately measure hormone levels, detect genetic abnormalities, and perform ultrasounds to assess the health of a patient’s reproductive organs. Additionally, it can help to identify any underlying medical conditions that could be contributing to infertility. Finally, advanced technology can be used to assess the quality of embryos during in vitro fertilization (IVF), helping to ensure that only healthy embryos are implanted.

 

Download PDF Brochure to Read More Details on This Topic

 

Key Players:

 

Global fertility test market was dominated  by Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brand Holdings (US) and Babystart (UK).

 

As of 2020, Swiss Precision Diagnostics holds the leading position in the global fertility test market. The company is one of the leading manufacturers and suppliers of fertility/ovulation tests for women. Clearblue is the flagship product of the company and has a very strong brand presence in countries such as the US, the UK, and Europe.

 

Church & Dwight (US) held the second position in the global fertility test market. The company has a strong geographic presence with subsidiaries across seven countries, including the UK, France, Germany, Canada, Mexico, Australia, and Brazil. Church & Dwight provides its fertility testing products to a large customer base through its wide distribution network across 130 countries.

 

Prestige Brands Holdings (US) is engaged in the manufacturing, marketing, and distribution of OTC healthcare and household cleaning products in the US, Canada, Australia, and other international markets. It sold its women’s healthcare, pregnancy, and fertility testing products under the brand e.p.t. As of January 2017, NFI Consumer Healthcare (US), a division of Gregory Pharmaceutical Holdings (US), acquired the e.p.t brand from Prestige Brands Holdings.

 

Key Growth Strategies Opted by Key Players:

 

The key growth strategies adopted by the top players in the market include product launches and approvals, agreements, expansions, and acquisitions. Product launches and enhancement were the most widely adopted growth strategies by market players in the last three years to garner a larger share of the market.

 

You Can Also Connect With Our Experts to Get Your Queries Answered

 

Opportunities Across Different Geographies:

 

Fertility testing is becoming increasingly popular as more couples seek to understand their fertility status and plan for their family. This industry has seen significant growth in recent years, and it is expected to continue to expand over the coming years. Different geographies offer different opportunities for companies in the fertility test industry.

 

In emerging markets such as India, the fertility test industry is still in its early stages. This offers companies the opportunity to enter the market and establish a strong presence. Companies must be prepared to invest in marketing and advertising, as well as providing quality products at competitive prices.

 

In the United States, the fertility test industry is well-established and mature. Companies have access to a large pool of potential customers, and the market is highly competitive. There is strong competition among companies offering fertility tests, and they must provide a high-quality product in order to stand out.

 

In Europe, the fertility test industry is well-established but still has room for growth. Companies can benefit from the advanced healthcare infrastructure and access to a large pool of potential customers. Companies must be prepared to invest in research and development to stay ahead of the competition, as well as to keep up with the latest technological advancements.

 

Overall, the fertility test industry offers a number of opportunities across different geographies. Companies must be prepared to invest in research and development, as well as marketing and advertising, in order to be successful in this industry. Additionally, they must be aware of the cultural and religious sensitivities in the local market when marketing the product. With the right approach, companies can take advantage of the opportunities in the fertility test industry across different geographies.

 

Content Source:

 


Monday, October 17, 2022

Global Fertility Test Market Size, Share & Trends - Forecasts to 2025

 Major Growth Driving Factors:


Growth in fertility test market is primarily driven by by the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and the increased awareness of fertility testing in both developed as well as developing countries.

Impact of COVID19:

The COVID-19 pandemic has emerged as a huge challenge for the global fertility test market. In the initial stages of the pandemic, authorities recommended the suspension of all in-person fertility treatments.

For instance, in March 2020, the American Society of Reproductive Medicine and the Canadian Fertility and Andrology Society announced their recommendations to instantly and for the foreseeable future suspend all in-person fertility treatments in the US and Canada due to COVID-19.

One in six reproductive-aged couples experiences infertility, and many turn to treatments such as IUI and IVF, which require several in-person appointments to complete. Around 3 million people seek infertility treatment in India every year, but only 0.5 million people undergo IVF/Intrauterine Insemination (IUI) procedure.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139945432

Challenge: High cost of fertility testing monitors

Price and brand recognition are two important criteria for the adoption of fertility testing kits and monitors across the globe. Being elective and non-reimbursable in nature, the price of a device is a prime determinant for its use. Although advanced branded fertility monitors possess high accuracy in identifying the fertility window, they are priced at a premium due to the high costs involved in maintaining brand loyalty, obtaining regulatory approvals, and incorporating the software in the systems. Owing to the high cost of these fertility monitors, a very limited number of patients in developing countries can afford them. This, in turn, is limiting the acceptance of these products, mainly in developing countries.

Recent Developments in the Global Fertility Testing Market:

# February 2021, Fertility Focus partnered with ExSeed Health, a home-based sperm testing company. Under this partnership, both companies would together provide solutions to couples planning a pregnancy.

# May 2019, Fertility Focus (UK) launched an updated version of OvuSense App— OvuSense App v.2—with features such as increased flexibility in data viewing (three different ways), more choices for logging events than most of the apps, and increased accuracy in terms of monitoring cycles.

# January 2017, NFI Consumer Healthcare (US), a division of Gregory Pharmaceutical Holdings (US), completed the acquisition of the e.p.t OTC pregnancy.

Opportunity: Emerging nations to offer new growth avenues

Emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities to players operating in the fertility testing market. The demand for fertility and ovulation monitors in emerging countries is expected to grow significantly in the coming years due to the rising infertility rates, increasing prevalence of PCOS and obesity, growing fertility education, and easy availability of fertility monitors through e-commerce websites, pharmacies, and retail shops/drugstores. In addition, friendly regulatory policies and less competition among players in developing markets (as compared to developed markets) have encouraged companies to focus on emerging countries.

Expected Revenue Growth, Globally:

The fertility test market is projected to reach USD 680 Million by 2025 from USD 472 Million in 2020, at a CAGR of 7.5% during the forecast period.

Request New Version of This Report@ https://www.marketsandmarkets.com/RequestNewVersion.asp?id=139945432

Geographical Growth:

North America dominated the global fertilty test market in 2020

North America, comprising the US and Canada, accounted for the largest share of the fertility testing market in 2020. The large share of this region can primarily be attributed to factors such as high prevalence of infertility, increasing awareness about fertility testing among women, the rising age of first-time pregnancies in women, and the easy availability of ovulation and fertility monitors through e-commerce websites.

Fertility Testing Market - End Users:

The home care settings segment is expected to register the highest CAGR during the forecast period

Based on end-users, the fertility test market has been segmented based on end-user category—home care settings, hospitals and fertility clinics, and other end users. The large share and high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions, easy access to fertility and ovulation monitors on e-commerce websites, availability of user-friendly and easy-to-handle devices, and the growing preference for the confidentiality of test results.

Tuesday, October 6, 2020

Fertility Test Market - Emerging Trends & Global Future Forecasts

 Market Dynamics:

Growth in the fertility test market can be attributed to factors such as the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and increased awareness of fertility testing in both developed as well as developing countries.

On the other hand, the unproven accuracy of urine-based ovulation monitors in women suffering from PCOS and the lesser precision to confirm ovulation using ovulation predictions kits are the factors that are expected to restrain market growth to a certain extent in the coming years.

The global fertility test market is expected to reach 583.1 million by 2023 from USD 411.8 million in 2018, at a CAGR of 7.2%.

Growth in the fertility test market can be attributed to factors, such as increasing first-time pregnancy age, launch of advanced, easy-to-use fertility monitors with high accuracy, and increasing awareness about fertility testing.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139945432

Recent Developments:

In 2017, Swiss Precision Diagnostics (Switzerland) launched its Clearblue Connected Ovulation Test System.
In 2017, NFI Consumer Healthcare (US) a division of Gregory Pharmaceutical Holdings (US) completed the acquisition of e.p.t over-the-counter pregnancy test kit brand from Prestige Brands Holdings.
In 2017, Fairhaven Health (US), launched TempCue, a basal body temperature (BBT) thermometer.
In 2016, Fertility Focus (UK) launched OvuSense App.

The ovulation predictor kits segment accounted for the largest share of the market by product in 2018

The fertility test market is segmented on the basis of product into ovulation predictor kits, fertility monitors, and male fertility testing products. The fertility monitors segment is further categorized into urine-based, saliva-based and other fertility monitors. The ovulation predictor kits segment commanded the largest share of the global fertility test market in 2018. This is primarily due to their high efficacy and low cost, high preference for these products, ease of use, low cost as compared to fertility monitors, and easy OTC availability.

Key Questions Addressed by the Report:

What are the growth opportunities related to the adoption of fertility test products across major regions in the future?
Emerging countries have immense opportunities for the growth and adoption of ovulation prediction kits. Will this scenario continue in the next five years?
Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
How will the increasing use of ovulation tracking mobile apps and fertility-tracking websites affect the growth of the market?

North America is expected to dominate the fertility test market during the forecast period.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global fertility test market during the forecast period (2018-2023). The large share can be attributed to the growing use of fertility monitoring devices for contraception and rising awareness about the benefits of ovulation monitors through social media, marketing campaigns, and e-commerce sites. In addition, the emergence of advanced easy-to-use fertility monitors with high accuracy is one of the key factors propelling the growth of the fertility test market in North America.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=139945432

Key Players:

The major players operating in the fertility test market include SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), and Prestige Brands Holdings (US), among others.

Analysis of the market developments between 2015 and 2018 revealed that several growth strategies such as product launches, enhancements, and strategic acquisitions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the fertility test market. Among these business strategies, product launches was the most widely adopted growth strategies by the players in the fertility test market.